Hubert H Fernandez MD

Movement Disorder

Professor of Medicine, Department of Neurology at Cleveland Clinic Lerner College of Medicine and Section Head of the Program for Movement Disorders, Center for Neurological Restoration at Cleveland Clinic

Join to View Full Profile

9500 Euclid AveCleveland, OH 44195
Phone+1 216-444-2200
Fax+1 216-636-2989

Education & Training

Boston University Medical CenterResidency, Neurology, 1995 - 1998
Pennsylvania Hospital of the University of Pennsylvania Health SystemInternship, Internal Medicine, 1994 - 1995
Virgen Milagrosa University Foundation College of MedicineClass of 1992

Certifications & Licensure

OH State Medical License 2010 - 2027
FL State Medical License 2003 - 2016
NV State Medical License 2010 - 2015
RI State Medical License 1999 - 2004
MA State Medical License 1997 - 2002
PA State Medical License 1994 - 1995
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Masked Faces in Parkinson Disease: Mechanism and Treatment Start of enrollment: 2004 Dec 01
Completed
Phase 2
Effects of Deep Brain Stimulation on Motor, Mood, and Cognitive Symptoms in Parkinson's Disease Start of enrollment: 2004 Jan 01
Completed
Not Applicable
rTMS for Motor and Mood Symptoms of Parkinson's Disease Start of enrollment: 2010 May 01
Completed
Not Applicable
Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression Start of enrollment: 2010 Jun 01
Completed
Phase 2
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States Start of enrollment: 2011 Feb 01
Completed
Safety and Tolerability of Perampanel in Cervical Dystonia Start of enrollment: 2017 Sep 01
Completed
Phase 1, Phase 2
Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease Start of enrollment: 2021 Oct 04
RECRUITING
PHASE1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

1 citations
Tardive dyskinesia versus tardive syndrome. What is in a name?
Karen Frei, Alicia Scott, Stanley N Caroff, Joseph Jankovic, William Ondo
Parkinsonism & Related Disorders. 2025-04-01
Cognitive measures predict falls in Parkinson's disease: Insights from the CYCLE-II cohort.
Saar Anis, Eric Zimmerman, A Elizabeth Jansen, Ryan D Kaya, Hubert H Fernandez
Parkinsonism & Related Disorders. 2025-04-01
Association of patient characteristics, social drivers of health, and geographic location on access to device-aided therapies among medicare beneficiaries with advance...
Joohi Jimenez-Shahed, Irene A Malaty, Michael Soileau, Connie H Yan, Lakshmi Kandukuri
Parkinsonism & Related Disorders. 2025-04-01

Journal Articles

Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients with Alzheimer's and Parkinson's Disease
Hubert Fernandez, Justis P Ehlers, Jagan A Pillai, Sunil K Srivastava, Robert Bermel, James B Leverenz, Investigative Ophthalmology and Visual Science
The Safety and Efficacy of Using the O‐Arm Intraoperative Imaging System for Deep Brain Stimulation Lead Implantation
Darlene A Lobel, Hubert H Fernandez, Andre G Machado, Sean J Nagel, Neuromodulation: Technology at the Neural Interface
Deutetrabenazine for Treatment of Involuntary Movements in Patients with Tardive Dyskinesia (AIM-TD): A Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial
Hubert H Fernandez, Robert A Hauser, The Lancet

Lectures

Advances in Alzheimer's Disease: An Update
Cleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Independence, Ohio - 5/11/2013
Shaping the Management Of Parkinson's Disease: Comprohensive Review Of Discoveries and Clinical Trials
Cleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Las Vegas, Nevada - 4/27/2013
Recognizing Parkinson’s Disease and Its Look-A-Likes: The 3rd Annual Weekend Symposium in Movement Disorders for the Busy Clinician
Cleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Cleveland, Ohio - 4/6/2013

Press Mentions

New Drug for Parkinson’s Shown to Be Effective in Clinical Trials: 'Very Encouraged'April 18th, 2025
AAN 2025: Tavapadon Offers Rapid, Sustained Motor BenefitsApril 11th, 2025
TEMPO: Tavapadon Shows Promise as Both First and Adjunct Therapy in Parkinson’sApril 11th, 2025
Join now to see all